Patent classifications
C
C12
C12Y
207/00
C12Y207/07
C12Y207/07083
C12Y207/07083
Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
11827663
·
2023-11-28
·
·
Disclosed are UAP inhibitors to inhibit glucose flux in the hexosamine biosynthetic pathway and methods of treating a disease using the inhibitors.
USE OF UAP INHIBITORS TO INHIBIT FLUX THROUGH THE HEXOSAMINE BIOSYNTHETIC PATHWAY
20210269468
·
2021-09-02
·
Disclosed are UAP inhibitors to inhibit glucose flux in the hexosamine biosynthetic pathway and methods of treating a disease using the inhibitors.
USE OF UAP INHIBITORS TO INHIBIT FLUX THROUGH THE HEXOSAMINE BIOSYNTHETIC PATHWAY
20180148468
·
2018-05-31
·
Disclosed are UAP inhibitors to inhibit glucose flux in the hexosamine biosynthetic pathway and methods of treating a disease using the inhibitors.